Microvast Q2 adj. EPS $(0.01) misses $0.01 est; sales miss by 7.6%
Microvast Holdings reported Q2 non-GAAP adjusted EPS of $(0.01), missing estimates, with revenue at $87.262M also falling short of consensus. The 4.46% YoY revenue drop was driven by a $2.7M tariff refund, but GAAP net loss improved significantly to $12.0M due to financial instrument valuation changes.
*this image is generated using AI for illustrative purposes only.
Microvast Holdings, Inc. reported second-quarter non-GAAP adjusted earnings per share (EPS) of $(0.01), missing the analyst consensus estimate of $0.01 by 200 percent. The Houston-based advanced battery technology company also saw quarterly sales of $87.262 million fall short of the $94.403 million estimate by 7.56 percent. This represents a 4.46 percent decline from $91.339 million in Q2 2025, driven primarily by a $2.7 million refund of tariffs imposed under the International Emergency Economic Powers Act (IEEPA) to a U.S. customer following a Supreme Court ruling.
The company’s GAAP net loss narrowed significantly to $12.0 million for the quarter ended June 30, 2026, compared to a $106.1 million net loss in the same period last year. This improvement was largely attributed to reduced negative impacts from changes in the fair value of warrant liability and convertible loan instruments. Despite the top-line pressure, Microvast maintained a gross margin of 29.5%, demonstrating resilience against raw material price fluctuations. However, operating expenses increased to $27.5 million from $23.7 million in the prior year period, reflecting continued investment in research and development.
Financial Performance Highlights
The divergence between GAAP and non-GAAP metrics underscores the impact of financial instrument valuations on reported results. While GAAP net loss per share improved to $0.03 from $0.33 in Q2 2025, non-GAAP adjusted net loss per share was $0.01, down from a profit of $0.05 per share in the prior year. Non-GAAP adjusted EBITDA decreased sharply to $3.6 million from $25.9 million in Q2 2025, indicating operational pressures despite the stabilization of financial liabilities.
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $87.262 million | $91.339 million | -4.46% |
| Gross Margin | 29.5% | 34.7% | -5.2 pts |
| Net Loss | $12.0 million | $106.1 million | Improved |
| Non-GAAP Adj. EPS | $(0.01) | $0.05 | Decreased |
| Capital Expenditures | $11.3 million | $7.4 million | Increased |
Yang Wu, Microvast’s Founder, Chairman, and Chief Executive Officer, highlighted the company’s progress through global capacity expansion. He noted that delivering $87.3 million in revenue while maintaining a 29.5% gross margin underscores the ability to navigate raw material fluctuations. Wu emphasized that returning the $2.7 million in IEEPA tariff refunds reinforces the strength of long-term commercial partnerships with U.S. customers.
Operational Outlook and Capacity Expansion
Looking ahead, Microvast is focusing on two key operational milestones for 2026. The Huzhou Phase 3.2 expansion is expected to deliver up to 2 GWh of next-generation modular capacity, supporting demand for advanced cell technologies. Additionally, localized pack assembly at the Clarksville facility is anticipated to commence operations by year-end, advancing the company’s domestic strategy to supply North American commercial vehicle and transit partners.
For the six months ended June 30, 2026, Microvast reported total revenues of $147.9 million, a 28.8% decrease from $207.8 million in the same period of 2025. This broader decline was influenced by evolving regulatory dynamics in Indian and Korean markets, demand shifts toward lower-cost products in India, and OEM platform ramp-up delays. Cash, cash equivalents, and restricted cash stood at $143.1 million as of June 30, 2026, compared to $169.2 million at the end of December 2025.
What the Numbers Show
The miss against analyst estimates highlights the sensitivity of Microvast’s near-term profitability to regulatory and tariff-related events. While the GAAP net loss narrowed dramatically due to reduced fair value losses on warrant liabilities, the non-GAAP adjusted EBITDA fell sharply from $25.9 million to $3.6 million. This suggests that underlying operational profitability faced headwinds from higher raw material prices and lower production utilization, which reduced fixed cost absorption. The company’s ability to maintain a 29.5% gross margin despite these factors indicates effective cost management, but the drop in adjusted EBITDA signals that operational efficiency remains under pressure as capacity ramps up.
How will the commencement of localized pack assembly at the Clarksville facility by year-end impact Microvast's ability to secure long-term contracts with North American commercial vehicle OEMs?
Given the 28.8% year-over-year revenue decline in H1 2026, what specific strategies is Microvast implementing to counteract demand shifts toward lower-cost products in the Indian market?
With cash reserves declining to $143.1 million and increased capital expenditures, does Microvast have sufficient liquidity to fund the Huzhou Phase 3.2 expansion without seeking additional equity financing?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
